News from chromadex corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:CDXC)

Dec 10, 2014, 06:30 ET

NIH Publishes Results of Preclinical Collaboration with ChromaDex Showing Potential Benefit of Nicotinamide Riboside

ChromaDex Corp.  (OTCQX: CDXC), announced today that the results of a mouse study performed in collaboration with ChromaDex by the National...

Dec 04, 2014, 06:30 ET

ChromaDex® CEO to Present at The Benchmark Company, LLC's Micro Cap Discovery One-on-One Conference on Dec. 11

ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Dec 03, 2014, 06:30 ET

ChromaDex® Receives $750,000 Cash from Previous Sale of its BluScience™ Line

 ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Dec 02, 2014, 08:00 ET

ChromaDex Licenses Exclusive Worldwide Patent Rights from the University of Mississippi for Microalgae Technology Targeting Immune Support

ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...

Nov 24, 2014, 08:25 ET

ChromaDex Announces Two Patent Issuances for Novel Ingredient, Pterostilbene

 The U.S. Patent and Trademark Office has granted patent #8,809,400 B2 (referred to as the '400 patent) and #8,841,350 B2 (referred to as the...

Nov 17, 2014, 08:25 ET

University of Birmingham Receives Grant from Wellcome Trust to Support Human Research on ChromaDex's NIAGEN® Nicotinamide Riboside

 ChromaDex Corp.  (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Nov 07, 2014, 17:00 ET

ChromaDex to Begin Trading on OTCQX Marketplace on November 10

ChromaDex®Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Nov 06, 2014, 06:40 ET

ChromaDex® Reports Ingredient Sales Grew 160% in the Third Quarter

 ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions...

Oct 06, 2014, 08:25 ET

New Edition of the Hayes' Principles and Methods of Toxicology Provides Critical New Chapter on Food Safety and Foodborne Toxicants

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Oct 01, 2014, 08:25 ET

Life Extension Introduces a New Anti-Aging Supplement, NAD+ Cell Regenerator™, Featuring NIAGEN™

 ChromaDex Corp.  (OTCQB: CDXC), Life Extension announced today the launch of NAD+ Cell Regenerator™, an innovative nutritional...

Sep 30, 2014, 06:30 ET

ChromaDex Secures $5.0 Million in Growth Capital Financing from Hercules

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...

Sep 22, 2014, 08:25 ET

University of California Irvine Completes Pterostilbene Study For Prevention of Skin Damage from UV Exposure

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Sep 11, 2014, 08:20 ET

ChromaDex and Healthy Directions enter into NIAGEN™ Supply Agreement

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Sep 04, 2014, 08:20 ET

ChromaDex Names Additional Scientific Advisory Board Members

ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Aug 06, 2014, 10:07 ET

ChromaDex's Ryan Dellinger to Speak at 248th American Chemical Society National Meeting

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based...

Jul 31, 2014, 08:25 ET

ChromaDex Signs Material Transfer Agreement With Prominent Australian Research Institute for NIAGEN™ Research

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Jun 19, 2014, 08:25 ET

ChromaDex Signs Collaboration Research Agreement with St. Jude Children's Research Hospital

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based...

May 28, 2014, 08:25 ET

ChromaDex and JQMS Announce Exclusive Sales and Marketing Agreement for GMP Compliance Services

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

May 13, 2014, 08:25 ET

ChromaDex Initiates Second Human Clinical Study for its Caffeine Ingredient, PURENERGY®

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

May 05, 2014, 08:25 ET

ChromaDex Signs Material Transfer Agreement With Wageningen University for NIAGEN™ Research

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...